Holen Sie sich die Stockscreener-App
46.92
2.05%
-0.98
Handel nachbörslich:
46.92
Schlusskurs vom Vortag:
$47.90
Offen:
$47.9
24-Stunden-Volumen:
419.84K
Relative Volume:
1.05
Marktkapitalisierung:
$987.47M
Einnahmen:
$1.77M
Nettoeinkommen (Verlust:
$-123.74M
KGV:
-5.1167
EPS:
-9.17
Netto-Cashflow:
$-95.21M
1W Leistung:
+3.69%
1M Leistung:
-20.77%
6M Leistung:
-27.85%
1J Leistung:
-12.33%
1-Tages-Spanne:
$46.31
$48.93
1-Wochen-Bereich:
$44.23
$49.10
52-Wochen-Spanne:
$26.70
$91.83
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
Firmenname
Praxis Precision Medicines Inc
Sektor
Branche
Telefon
617-300-8460
Adresse
99 HIGH STREET, 30TH FLOOR, BOSTON
Vergleichen Sie PRAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRAX
Praxis Precision Medicines Inc
|
46.92 | 1.01B | 1.77M | -123.74M | -95.21M | -9.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-03 | Bestätigt | H.C. Wainwright | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-08-05 | Eingeleitet | Oppenheimer | Outperform |
| 2024-06-24 | Eingeleitet | Needham | Buy |
| 2024-06-18 | Eingeleitet | Guggenheim | Buy |
| 2024-05-01 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-09-19 | Eingeleitet | Truist | Buy |
| 2022-06-06 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-08-26 | Eingeleitet | BofA Securities | Buy |
| 2021-04-26 | Eingeleitet | William Blair | Outperform |
| 2020-11-11 | Eingeleitet | Wedbush | Outperform |
| 2020-11-10 | Eingeleitet | Cowen | Outperform |
| 2020-11-10 | Eingeleitet | Evercore ISI | Outperform |
| 2020-11-10 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Praxis Precision Medicines Inc Aktie (PRAX) Neueste Nachrichten
How to read the order book for Praxis Precision Medicines Inc.July 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - Newser
How sentiment analysis helps forecast Praxis Precision Medicines Inc.2025 Historical Comparison & Accurate Intraday Trade Tips - Newser
Published on: 2025-08-27 11:04:13 - Newser
Published on: 2025-08-27 10:56:50 - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc.PRAX - PR Newswire
Using AI based signals to follow Praxis Precision Medicines Inc.Quarterly Market Review & Accurate Buy Signal Notifications - Newser
Deutsche Bank AG Decreases Position in Praxis Precision Medicines, Inc. $PRAX - Defense World
Comparing Praxis Precision Medicines Inc. in custom built stock radarsEarnings Trend Report & Trade Opportunity Analysis Reports - Newser
How to build a dashboard for Praxis Precision Medicines Inc. stockEarnings Beat & Safe Swing Trade Setups - Newser
Reversal indicators forming on Praxis Precision Medicines Inc. stockPrice Action & Stepwise Entry and Exit Trade Signals - Newser
Published on: 2025-08-26 18:53:26 - Newser
News impact scoring models applied to Praxis Precision Medicines Inc.Market Risk Summary & Long-Term Capital Growth Ideas - Newser
Analyzing Praxis Precision Medicines Inc. with risk reward ratio chartsWeekly Profit Report & Detailed Earnings Play Strategies - Newser
Praxis Precision Medicines, Inc. (PRAX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Can machine learning forecast Praxis Precision Medicines Inc. recoveryJuly 2025 Short Interest & AI Powered Market Entry Ideas - Newser
Top chart patterns to watch in Praxis Precision Medicines Inc.2025 Earnings Surprises & Verified High Yield Trade Plans - Newser
Swiss National Bank Has $1.03 Million Stock Position in Praxis Precision Medicines, Inc. $PRAX - Defense World
Measuring Praxis Precision Medicines Inc.’s beta against major indicesWeekly Investment Recap & Weekly Top Stock Performers List - Newser
Praxis Precision Medicines to Present Recent Epilepsy Study Results at International Epilepsy Congress 2025 - Quiver Quantitative
Praxis Medicines to Present at 36th International Epilepsy - GlobeNewswire
Praxis Precision Medicines, Inc. to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline - MarketScreener
Evaluating Praxis Precision Medicines Inc. with trendline analysisQuarterly Trade Review & Consistent Income Trade Ideas - Newser
Is Praxis Precision Medicines Inc. reversing from oversold territoryMarket Growth Review & High Conviction Investment Ideas - Newser
Tools to monitor Praxis Precision Medicines Inc. recovery probabilityJuly 2025 Closing Moves & Target Return Focused Stock Picks - Newser
Top chart patterns to watch in Praxis Precision Medicines IncJuly 2025 Breakouts & Technical Buy Zone Confirmations - Newser
Can Praxis Precision Medicines Inc. benefit from deglobalization2025 Buyback Activity & Smart Investment Allocation Insights - theviewers.co.kr
Market Review: Can Praxis Precision Medicines Inc. be recession proofJuly 2025 EndofMonth & Safe Entry Zone Tips - sundaytimes.kr
Can Praxis Precision Medicines Inc. rally from current levelsMarket Volume Summary & Fast Exit and Entry Strategy Plans - Newser
What Technical Tools Say About Praxis Precision Medicines Inc. RecoveryJuly 2025 Price Swings & Entry and Exit Point Strategies - beatles.ru
Praxis Precision Medicines Under Investigation for Securities Law Violations - AInvest
PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Praxis Precision Medicines, Inc. (PRAX) And Encourages Investors to Connect - ACCESS Newswire
Intraday Charts Show Spike in Praxis Precision Medicines Inc. ActivityStop Loss & Free Real-Time Market Sentiment Alerts - 더경남뉴스
Praxis Precision Medicines Inc. stock momentum explainedQuarterly Investment Review & Safe Entry Trade Reports - Newser
Advanced analytics toolkit walkthrough for Praxis Precision Medicines Inc.Weekly Earnings Recap & AI Powered Buy/Sell Recommendations - Newser
Praxis Precision Medicines Inc. stock retracement – recovery analysisJuly 2025 Update & Fast Gain Stock Trading Tips - Newser
Momentum Screeners Rank Praxis Precision Medicines Inc. in Top 5 TodayJuly 2025 News Drivers & Detailed Earnings Play Alerts - beatles.ru
Finanzdaten der Praxis Precision Medicines Inc-Aktie (PRAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):